BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,565,000 | +26.0% | 10,741 | +2.6% | 0.06% | +53.7% |
| Q1 2022 | $1,242,000 | -10.9% | 10,473 | +3.5% | 0.04% | 0.0% |
| Q4 2021 | $1,394,000 | +28.5% | 10,114 | +29.5% | 0.04% | +20.6% |
| Q3 2021 | $1,085,000 | +42.4% | 7,811 | -0.5% | 0.03% | +54.5% |
| Q2 2021 | $762,000 | +42.4% | 7,852 | +0.2% | 0.02% | +37.5% |
| Q1 2021 | $535,000 | -22.6% | 7,833 | -2.9% | 0.02% | -27.3% |
| Q4 2020 | $691,000 | -37.6% | 8,063 | -60.4% | 0.02% | -40.5% |
| Q4 2019 | $1,107,000 | +9.1% | 20,342 | -25.1% | 0.04% | +5.7% |
| Q3 2017 | $1,015,000 | – | 27,164 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |